盘龙药业
(002864)
| 流通市值：22.12亿 | | | 总市值：31.69亿 |
| 流通股本：7419.07万 | | | 总股本：1.06亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 841,452,392.85 | 574,023,000.14 | 250,212,341.68 | 973,864,163.02 |
| 营业收入 | 841,452,392.85 | 574,023,000.14 | 250,212,341.68 | 973,864,163.02 |
| 二、营业总成本 | 735,238,373.82 | 502,134,108.31 | 213,738,632.71 | 843,758,147.88 |
| 营业成本 | 398,130,242.64 | 280,795,329.78 | 115,323,173.18 | 381,516,125.9 |
| 税金及附加 | 8,717,179.22 | 5,814,253.63 | 2,810,045.06 | 11,168,819.68 |
| 销售费用 | 271,151,667.7 | 181,091,647.12 | 84,211,349.04 | 367,022,980.07 |
| 管理费用 | 45,830,797.56 | 30,440,491.49 | 13,407,202.35 | 69,834,307.62 |
| 研发费用 | 24,095,842.41 | 15,850,091.6 | 4,642,275.19 | 37,537,758.87 |
| 财务费用 | -12,687,355.71 | -11,857,705.31 | -6,655,412.11 | -23,321,844.26 |
| 其中:利息费用 | 2,389,236.85 | 1,518,547.12 | 723,785.66 | 1,561,122.08 |
| 其中:利息收入 | 15,130,141.83 | 13,415,920.16 | 7,393,346.51 | 24,947,082.05 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -174,193.12 | -119,497.29 | -53,134.09 | 630,894.09 |
| 资产处置收益 | 129,676.24 | -10,511.53 | -315.97 | -14,127.67 |
| 资产减值损失(新) | -211,235.57 | -187,608.28 | 55,058.78 | -225,002.29 |
| 信用减值损失(新) | -7,348,593.36 | -9,173,057.09 | -2,360,867.47 | -2,220,668.36 |
| 其他收益 | 9,329,693.65 | 8,264,779.16 | 2,110,821.88 | 10,089,903.59 |
| 四、营业利润 | 107,939,366.87 | 70,662,996.8 | 36,225,272.1 | 138,367,014.5 |
| 加:营业外收入 | 73,447.75 | 54,604.7 | 1,310.4 | 193,542.49 |
| 减:营业外支出 | 1,303,573.32 | 656,224.97 | 7,398.14 | 1,608,733.37 |
| 五、利润总额 | 106,709,241.3 | 70,061,376.53 | 36,219,184.36 | 136,951,823.62 |
| 减:所得税费用 | 17,106,813.44 | 10,081,903.02 | 5,053,342.39 | 17,027,133.71 |
| 六、净利润 | 89,602,427.86 | 59,979,473.51 | 31,165,841.97 | 119,924,689.91 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 89,602,427.86 | 59,979,473.51 | 31,165,841.97 | 119,924,689.91 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 89,805,874.28 | 60,135,150.47 | 31,249,274.14 | 120,271,592.81 |
| 少数股东损益 | -203,446.42 | -155,676.96 | -83,432.17 | -346,902.9 |
| 扣除非经常损益后的净利润 | 82,470,089.55 | 52,857,463.86 | 28,752,863.99 | 112,605,328.41 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.85 | 0.57 | 0.3 | 1.15 |
| (二)稀释每股收益 | 0.85 | 0.57 | 0.3 | 1.15 |
| 九、综合收益总额 | 89,602,427.86 | 59,979,473.51 | 31,165,841.97 | 119,924,689.91 |
| 归属于母公司股东的综合收益总额 | 89,805,874.28 | 60,135,150.47 | 31,249,274.14 | 120,271,592.81 |
| 归属于少数股东的综合收益总额 | -203,446.42 | -155,676.96 | -83,432.17 | -346,902.9 |
| 公告日期 | 2025-10-28 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |